Search Results for: covid-19
Articles
FDA Approves Octapharma USA Investigational New Drug Application for Severe COVID-19 Patients
The US FDA has recently approved the investigational new drug (IND) application submitted by Octapharma USA for a Phase 3 clinical trial on…
CanSino Biologics & Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine
CanSino Biologics Inc. and Precision NanoSystems (PNI) recently announced a co-development agreement of a mRNA lipid nanoparticle (mRNA-LNP) vaccine against COVID-19. The parties will…
CureVac´s Optimized mRNA Platform Provides Positive PreClinical Results at Low Dose for COVID-19 Vaccine Candidate
CureVac AG recently announced positive preclinical results at a low dose for its lead vaccine candidate against the novel Coronavirus...COVID-19’s Effect Will Boost Infectious Disease Drug Approvals & Present Opportunities to CMOs
In response to the global pandemic, biopharma companies have put a renewed emphasis on finding treatments for infectious diseases, including COVID-19 and other infectious diseases overall…..
Akers Biosciences & Premas Biotech Announce Successful Completion of COVID-19 Vaccine Prototype & Obtained First Images of VLP
Akers Biosciences, Inc. recently announced that Premas Biotech, its partner in the development of a vaccine candidate that is seeking to address the COVID-19 pandemic…..
Catalent Partners With Humanigen to Support FDA-Approved Phase 3 Lenzilumab Study for COVID-19
Catalent recently welcomed the news by Humanigen, Inc., that it has dosed the first COVID-19 patient in its previously announced...Evelo Biosciences, Rutgers University & Robert Wood Johnson University Hospital Announce Submission of IND for Phase 2 Study of EDP1815 in COVID-19 Patients
Evelo Biosciences, Inc., Rutgers University, and Robert Wood Johnson University Hospital recently announced the submission of an Investigational New Drug...AI VIVO Seeks Collaboration Partners to Progress Top-Ranked COVID-19 Therapeutic Candidates
AI VIVO recently announced it is seeking pharma and biotech collaboration partners to progress therapeutic candidates that have been identified...Singota Solutions Collaborates With Noveome Biotherapeutics to Manufacture Promising Therapy to Treat Severe Condition in People Infected with COVID-19
Singota Solutions has been selected to collaborate with Noveome Biotherapeutics, Inc. to manufacture the ST266 investigational drug product, a biologic being evaluated in….
Proveris Scientific Announces Contract Test Services to Support Development of SARS-CoV-2 (COVID-19) Inhaled Drug Therapies & Vaccines
Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, recently announced the availability of contract test services to support….
